EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Systematic review of pulmonary and cardiovascular disease among asphalt pavers

A Sandvik, M D Bugge, K -C Nordby, I L Jørgensen, B G Randem, G Smedslund, G E Vist, B C Brinchmann

Occupational Medicine · 2026-11-06

DOI: 10.1093/occmed/kqag063 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Asphalt pavers may be exposed to a wide range of potentially hazardous substances, and an annual decline in lung function among asphalt pavers has been reported. Studies reporting a modest increase in lung cancer mortality among asphalt workers have been thoroughly summarized and reviewed. Aims The aim of this paper was to systematically review and meta-analyse mortality from non-malignant pulmonary diseases and cardiovascular disease (CVD) associated with asphalt paving (PROSPERO Nr CRD42022341463). Methods A librarian conducted a literature search in February 2024. We included human studies, assessed risk of bias, conducted meta-analysis and assessed confidence in effect-estimates using GRADE. We included cohort studies reporting estimates on mortality from non-malignant pulmonary disease and CVD among asphalt pavers compared with referents. Results We included 10 cohort studies (3714 to 248 087 participants). Asphalt paving was associated with standardized mortality ratio (SMR) from all causes of 0.94 (95% CI 0.81-1.07), SMR from non-malignant pulmonary disease was 1.19 (95% CI 0.95-1.42), whereas SMR from CVD was 0.88 (95% CI 0.75–1.02). Conclusions Our study gave no support to the hypothesis linking asphalt work to excess mortality from cardiovascular or non-malignant pulmonary disease. The studies were not adequately adjusted for confounders. Healthy worker bias may have affected the results. From the GRADE assessment we are uncertain (very low confidence) about the association between asphalt paving and mortality from cardiovascular or non-malignant pulmonary disease. New studies, especially on non-malignant pulmonary disease with better control of confounding factors are warranted.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →